KROS: Keros Therapeutics Inc

14.41 USD 0.25 (1.71%)

Secteur: Soins de Santé Base: US Dollar Devise de profit: US Dollar

Le taux de change de KROS a changé de -1.71% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 14.35 et à un maximum de 14.80.

Suivez la dynamique Keros Therapeutics Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.

Graphique en Plein Ecran

KROS Nouvelles

Zacks 15:40 KROS vs. EXAS: Which Stock Should Value Investors Buy Now?
Zacks 14:54 Will Reblozyl Enable BMY to Offset the Impact of Generic Competition?
Seeking Alpha 13:50 ClearBridge Small Cap Strategy Q2 2025 Commentary
Zacks 15:28 RCKT Stock Up on FDA's RMAT Tag to Gene Therapy for Heart Failure
Zacks 14:39 FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo
Investing 12:05 Keros Therapeutics doses first patient in Phase 3 MDS trial
Reuters 14:41 Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Benzinga 18:37 Keros Therapeutics' Quiet Near-Term Outlook Overshadows Pipeline Potential: Analyst - Keros Therapeutics (NASDAQ:KROS)
Investing 09:05 BofA cuts Keros Therapeutics stock rating, price target to $18
Investing 19:17 Keros directors face significant shareholder dissent
Investing 11:01 Keros Therapeutics to return $375 million to shareholders
Investing 20:16 Keros Therapeutics Announces Participation at Goldman Sachs 46th Annual Global Healthcare Conference
Benzinga 16:54 Keros Therapeutics Stops PAH Drug Development, Shrinks Workforce By 45% - Keros Therapeutics (NASDAQ:KROS)
Investing 10:57 Keros Therapeutics halts PAH drug development, cuts workforce
Investing 17:48 Keros secures Glass Lewis support for director nominees
Investing 12:14 ADAR1 calls for Keros to release review results before vote
Investing 12:28 Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value
Seeking Alpha 18:13 Keros Therapeutics (KROS): Strategic Alternatives Could Bring About Value Creation
Benzinga 17:51 Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan - Keros Therapeutics (NASDAQ:KROS)
Benzinga 16:12 Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump - CarMax (NYSE:KMX), Keros Therapeutics (NASDAQ:KROS)
Benzinga 14:05 PriceSmart Posts Better-Than-Expected Earnings, Joins Enact Holdings, DexCom And Other Big Stocks Moving Higher On Thursday - Enact Holdings (NASDAQ:ACT), DexCom (NASDAQ:DXCM)
Seeking Alpha 22:25 Keros Therapeutics: Losing Its Lead Drug Is Bad Medicine (NASDAQ:KROS)
Seeking Alpha 14:01 Fidelity Select Health Care Portfolio Q4 2024 Review (Mutual Fund:FSPHX)

Range quotidien

14.35 14.80

Range Annuel

9.12 72.37

Clôture Précédente: 14.48
Ouverture: 14.66

Bid: 14.41
Ask: 14.71

Plus Bas: 14.35
Plus Haut: 14.80

Volume: 812

Changement quotidien: -1.71%
Changement Mensuel: 8.18%

Changement à 6 Mois: 29.59%
Changement Annuel: -71.40%

30 juillet, mercredi